» Articles » PMID: 20051674

Guiding Policy Decisions for Genetic Screening: Developing a Systematic and Transparent Approach

Overview
Specialties Genetics
Public Health
Date 2010 Jan 7
PMID 20051674
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

With the ever-widening gap between what is technologically possible and services available, jurisdictions around the world are faced with complex decisions regarding the introduction and expansion of genetic screening programs. A series of literature reviews and consultations with stakeholders and experts led to the development of a decision support guide for genetic screening policy-making. This involved establishing a preliminary list of core criteria synthesized from the growing literature on genetic screening, which was then transformed through a series of consultations into a more elaborate decision guide. Although certain perennial challenges in genetic screening policy-making remain, the decision support guide aims to promote a fair and evidence-informed process that makes explicit the ethical dilemmas often inherent to such policy decisions.

Citing Articles

Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditions.

Freeman L, Archibald A, Dive L, Delatycki M, Kirk E, Laing N Eur J Hum Genet. 2024; 33(2):194-198.

PMID: 39587355 PMC: 11840106. DOI: 10.1038/s41431-024-01738-0.


Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?.

Schnabel-Besson E, Mutze U, Dikow N, Horster F, Morath M, Alex K Int J Neonatal Screen. 2024; 10(3).

PMID: 39311364 PMC: 11417796. DOI: 10.3390/ijns10030062.


Newborn screening in Germany.

Tonnies H, Nennstiel U Med Genet. 2024; 34(1):1-2.

PMID: 38836012 PMC: 11006363. DOI: 10.1515/medgen-2022-2119.


Australian public perspectives on genomic newborn screening: which conditions should be included?.

Lynch F, Best S, Gaff C, Downie L, Archibald A, Gyngell C Hum Genomics. 2024; 18(1):45.

PMID: 38720401 PMC: 11077791. DOI: 10.1186/s40246-024-00611-x.


A Delphi Survey Study to Formulate Statements on the Treatability of Inherited Metabolic Disorders to Decide on Eligibility for Newborn Screening.

Veldman A, Kiewiet M, Westra D, Bosch A, Brands M, de Coo R Int J Neonatal Screen. 2023; 9(4).

PMID: 37873847 PMC: 10594494. DOI: 10.3390/ijns9040056.